Mr. Rubin joined Trout’s team in 2005 after co-heading the Biotechnology Capital Markets Intelligence Group at Thomson Financial, assisting over 60 life sciences companies in their understanding of Wall Street. He brings with him over ten years of experience in advising life science companies on topics including shareholder targeting, capital markets transactions, message crafting and scenario analysis. His experience includes work in finance, consulting and market analysis. He has been involved with companies from pre-IPO stages to follow-on and convertible offerings. He is involved in capital transactions with corporate clients and has counseled clients on domestic and cross-border transactions and binary data events.
Chad holds a Bachelor of Arts degree in business administration with a concentration in finance from Franklin & Marshall College. He has a minor in film and media studies. He also holds Series 7, 79 and 63 securities licenses.